Immunotherapy - Tumors

The mainstay of cancer treatment has historically involved therapies, such as surgery, chemotherapy or radiation that were developed without regard for the patient's immune system. These therapies include nonspecific activation of the immune system using toll‐like receptor ligands, cytokines or immune checkpoint inhibitors, or specific treatments, like monoclonal antibody administration or vaccination, that directly target cancer cells. Perhaps, the most promising specific therapy is the adoptive transfer of genetically engineered tumour‐reactive T cells, an approach that has already proven curative in some patients with metastatic disease. Cumulatively, these new immune‐based approaches have great promise to revolutionise cancer therapy

  • Immune system stimulants
  • Tumor antigens
  • Anti tumor response
  • Out comes

Related Conference of Immunotherapy - Tumors

April 04-05, 2024

38th International Conference on Immunology

Madrid, Spain
May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland

Immunotherapy - Tumors Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in